Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,370.30
-13.10 (-0.95%)
At close: Oct 7, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 168.26 billion as of October 7, 2026. Its market cap has increased by 46.96% in one year.
Market Cap
168.26B
Enterprise Value
161.01B
Revenue
25.90B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.17
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 168.26B, an increase of 83.47%. That is a compound annual growth rate of 12.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 168.26B | 49.63% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 275.80B |
| Shilpa Medicare | 208.03B |
| Suven Life Sciences | 87.17B |
| Symbiotec Pharmalab | 76.98B |
| IOL Chemicals and Pharmaceuticals | 61.48B |
| Gujarat Themis Biosyn | 49.76B |
| NGL Fine-Chem | 18.07B |
| Bajaj HealthCare | 10.89B |